Adjuvant intraperitoneal chemotherapy for the treatment of gastric cancer at risk for peritoneal carcinomatosis: A systematic review. Issue 2 (23rd November 2016)

• Record Type: Journal Article
• Authors: Feingold, Paul L.; Kwong, Mei Li M.; Davis, Jeremy L.; Rudloff, Udo
• Is Part Of: Journal of surgical oncology. Volume 115:Issue 2(2017)
• Page Start: 192
• Page End: 201
• Publication Date: 2016-11-23
• Subjects: heated intraperitoneal chemotherapy (HIPEC) -- adjuvant regional chemotherapy -- gastrointestinal malignancies -- peritoneal carcinomatosis -- systematic review; Cancer -- Surgery -- Periodicals; Neoplasms -- Periodicals; 616
• DOI: 10.1002/jso.24476
• Languages: English
• ISSNs: 0022-4790

Abstract

Abstract : The peritoneal surface is a frequent site of recurrence following surgery for gastric cancer. A systematic review and random effect analysis was undertaken to analyze current literature regarding the role of adjuvant intraperitoneal chemotherapy in gastric cancer. While pooled analysis supports the use of adjuvant IP chemotherapy in resectable gastric cancer, maximal benefit occured with intra‐operative delivery, and possibly the use of MMC. J. Surg. Oncol. 2017;115:192–201 . © 2016 Wiley Periodicals, Inc.